Critical Care, 2 weeks ago
Get to kidneys - 24.kg, 3 weeks ago
Early mobilization on continuous renal replacement therapy is safe and may improve filter life - Critical Care, 1 month ago
More from: Current Opinion in Allergy and Clinical Immunology, Sexual Development...and 2 other sources
1 images for "continuous renal replacement therapy"
The ceremonial handing over of the the Continuous Renal Replacement Therapy (CRRT) machine donated Access International to the medical intensive care unit was held at the Lady Ridgeway Hospital on Tuesday at the new auditorium under the patronage of ...Sri Lanka Daily News, 2 months ago J&K Bank to donate CRRT & Colour Doppler Ultrasound machines to SKIMS Kashmir Times, 3 weeks ago J&K Bank donates CRRT, Colour Doppler to SKIMS Daily Excelsior.com, 3 weeks ago
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Commentary Jan J De Waele and Mieke Carlier Critical Care 2014, 18 :158Critical Care, 2 months ago Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines? Critical Care, 2 months ago Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy Critical Care, 2 months ago
Migalastat Successfully Meets Both Co-Primary Endpoints of Comparability to Enzyme Replacement Therapy (ERT) on Both Key Measures of Kidney Function Comparability to ERT Also Demonstrated in Important Fabry Disease Biomarker, Plasma Lyso-Gb3 ...CEOWorld Magazine, 1 week ago AMICUS THERAPEUTICS : Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 4 Traders, 1 week ago Amicus Therapeutics ( FOLD ) Stock Junction, 1 month ago Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 Market Pulse Navigator, 2 months ago
The present invention is directed to a stable fluorocarbon emulsion having a continuous aqueous phase and discontinuous fluorocarbon phase comprising two fluorocarbons and surprisingly demonstrates that perfluorodecyl bromide is as effective in ...PharmCast, 2 months ago
Amicus Therapeutics, Inc., a biopharmaceutical company, has announced positive 18-month data from its second Phase III study, or Study 012, with an oral small molecule chaperone, migalastat HCl, in Fabry patients with amenable mutations. Study 012 ...Individual.com, 2 days ago Amicus Therapeutics, Inc. Rockets On Positive Phase 3 Study Data For Rare Disease Drug; Stock Up +21.66% At 11:38AM ET On Wednesday BioSpace, 1 week ago
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)
Operator Good day, ladies and gentlemen, and welcome to the Amicus Phase 3 Fabry monotherapy results conference call. At this time all participants are in a listen only mode. Later we will conduct a question-and-answer session and instructions ...Seeking Alpha, 1 week ago Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript Seeking Alpha, 3 weeks ago
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and ...General Medicine eJournal, 1 month ago
FDA Approves Genzyme's Cerdelga (eliglustat) Capsules First-Line Oral Therapy Approved for the Treatment of Adults with Gaucher Disease Type 1 CAMBRIDGE, Mass., Aug 19, 2014 (BUSINESS WIRE) -- Genzyme, a Sanofi company , announced today that ...BioSpace, 1 week ago 8/19/14 - FDA Approves Genzyme??s Cerdelga?¢ (eliglustat) Capsules Pharmacy Choice, 1 week ago FDA Approves Genzyme's Cerdelga (eliglustat) Capsules FierceBiotech, 1 week ago FDA Approves Genzyme's Cerdelga(TM) (eliglustat) Capsules CNBC, 1 week ago
(GLOBE NEWSWIRE) -- . (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary ...Pettinga Financial Advisors, 4 weeks ago Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call Yahoo! Finance, 1 month ago Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA Individual.com, 2 months ago Rockwell Medical Receives FDA Approval for Calcitriol Yahoo! Finance, 2 months ago
on your WebpageAdd Widget >Get your members hooked!